R&G PharmaStudies Co., Ltd. (SHE:301333)
63.47
-2.36 (-3.58%)
At close: Apr 29, 2026
43.40% (1Y)
| Market Cap | 6.09B |
| Revenue (ttm) | 896.26M |
| Net Income (ttm) | 133.65M |
| Shares Out | 95.99M |
| EPS (ttm) | 1.40 |
| PE Ratio | 45.29 |
| Forward PE | 36.69 |
| Dividend | 0.16 (0.24%) |
| Ex-Dividend Date | Jul 8, 2025 |
| Volume | 1,460,440 |
| Average Volume | 2,416,680 |
| Open | 65.29 |
| Previous Close | 65.83 |
| Day's Range | 63.41 - 65.60 |
| 52-Week Range | 43.05 - 91.78 |
| Beta | 0.70 |
| RSI | 47.07 |
| Earnings Date | Apr 28, 2026 |